title: Photo-induced erythema multiforme associated with vandetanib administration.
authors.affiliation: Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain. Electronic address: mdcaro@fhalcorcon.es.
authors.forename: Dolores
authors.initials: D
authors.lastname: Caro-Gutiérrez
authors.affiliation: Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
authors.forename: Maria Uxúa
authors.initials: MU
authors.lastname: Floristán Muruzábal
authors.affiliation: Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
authors.forename: Enrique
authors.initials: E
authors.lastname: Gómez de la Fuente
authors.affiliation: Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
authors.forename: Ana Pampín
authors.initials: AP
authors.lastname: Franco
authors.affiliation: Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
authors.forename: José Luis
authors.initials: JL
authors.lastname: López Estebaranz
mesh_terms: D000368:Aged; D001707:Biopsy, Needle; D018276:Carcinoma, Medullary / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009367:Neoplasm Staging; D010787:Photosensitivity Disorders / Q000139:chemically induced* / Q000473:pathology; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013965:Thyroidectomy / Q000379:methods
chemical_list: D010880:Piperidines; D011799:Quinazolines; C452423:vandetanib